TNF and pneumonia: With advances in nanotechnology, Noh and colleagues developed cellular nanodiscs derived from P. aeruginosa OMVs, which enhanced both cellular and humoral immune responses, protecting against pneumonia by reducing the lung bacterial loads and pro-inflammatory cytokines (IL-12, IL-17A and TNF-α) [223].